virus vector-based gene therapy (Actis Biologics)

N/A

Report date: 2025/03/20 20:00:06

Base Information

Drug Namevirus vector-based gene therapy (Actis Biologics)
Drug Alias NameN/A
ClassificationCell and gene therapy > Gene therapy > Viral vector-based gene therapy
Mechanisms of ActionAngiogenesis inhibitors
TargetsUpdating
Therapy Area/IndicationsProstatic NeoplasmsBreast Neoplasms
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryUnited States
CombinationsNo
Global Highest StatusPending (Preclinical)
Highest Status in ChinaN/A
Originator CompaniesActis Biologics Inc
China Registration ClassN/A

Develop Information

Active CompaniesN/A
Inactive CompaniesActis Biologics Inc
Active IndicationsN/A
Inactive IndicationsProstatic NeoplasmsBreast Neoplasms

Other Information

ATC CodeN/A
Related LinksN/A